You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification

Article info

Article menu

Download PDFPDF

XML
Research Article
Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification

Authors

  • Anne Monette Institut du cancer de Montréal Montréal Québec Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) 900 rue St-Denis, Tour Viger, Room R10-432 H2X 0A9 Montréal Québec Canada Département de Médecine, Faculté de MédecineUniversité de Montréal Montréal Canada PubMed articlesGoogle scholar articles
  • Derek Bergeron Département de Médecine, Faculté de MédecineUniversité de Montréal Montréal Canada PubMed articlesGoogle scholar articles
  • Amira Ben Amor Medicine Faculty of Tunis, Department of Immunology and HistologyTunis El Manar University Tunis Tunisia PubMed articlesGoogle scholar articles
  • Liliane Meunier Institut du cancer de Montréal Montréal Québec Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) 900 rue St-Denis, Tour Viger, Room R10-432 H2X 0A9 Montréal Québec Canada PubMed articlesGoogle scholar articles
  • Christine Caron Institut du cancer de Montréal Montréal Québec Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) 900 rue St-Denis, Tour Viger, Room R10-432 H2X 0A9 Montréal Québec Canada PubMed articlesGoogle scholar articles
  • Anne-Marie Mes-Masson Institut du cancer de Montréal Montréal Québec Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) 900 rue St-Denis, Tour Viger, Room R10-432 H2X 0A9 Montréal Québec Canada Département de Médecine, Faculté de MédecineUniversité de Montréal Montréal Canada PubMed articlesGoogle scholar articles
  • Nidhameddine Kchir Department of PathologyLa Rabta Hospital of Tunis Tunis Tunisia PubMed articlesGoogle scholar articles
  • Kamel Hamzaoui Medicine Faculty of Tunis, Department of Immunology and HistologyTunis El Manar University Tunis Tunisia Abderrahmen Mami HospitalHomeostasis and cell immune dysfunction Research Unit Ariana Tunisia PubMed articlesGoogle scholar articles
  • Igor Jurisica Krembil Research Institute, UHN 60 Leonard Avenue M5T 0S8 Toronto Ontario Canada Institute of NeuroimmunologySlovak Academy of Sciences Bratislava Slovak Republic PubMed articlesGoogle scholar articles
  • Réjean Lapointe Institut du cancer de Montréal Montréal Québec Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) 900 rue St-Denis, Tour Viger, Room R10-432 H2X 0A9 Montréal Québec Canada Département de Médecine, Faculté de MédecineUniversité de Montréal Montréal Canada PubMed articlesGoogle scholar articles

Citation

Monette A, Bergeron D, Ben Amor A, et al
Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification
Journal for ImmunoTherapy of Cancer 2019;7:86. doi: 10.1186/s40425-019-0544-x
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.